The following pages link to Heiko Götte (Q108608):
Displayed 5 items.
- Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology (Q108613) (← links)
- Utility‐based optimization of phase II/III programs (Q5978234) (← links)
- Optimal designs for phase II/III drug development programs including methods for discounting of phase II results (Q5978235) (← links)
- Optimal Designs for Multi-Arm Phase II/III Drug Development Programs (Q5978236) (← links)
- Optimal planning of phase II/III programs for clinical trials with multiple endpoints (Q5978237) (← links)